Business Standard

Sunday, January 19, 2025 | 04:08 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Bharat Bio's nasal Covid vaccine to cost Rs 800/dose in private market

Price at Rs 325 per dose for large-volume government procurement, will be on sale late January

Bharat Biotech's intranasal Covid vaccine
Premium

Bharat Biotech's intranasal Covid vaccine

Sohini Das Mumbai
Bharat Biotech’s iNCOVACC, the first intranasal Covid-19 vaccine approved for mix-and match booster inoculation, is priced at Rs 800 per dose for private market and at Rs 325 for large-volume government procurement.

The vaccine is available on the government's CoWIN website and it will be in the market by the fourth week of January, said the Hyderabad-based company.

Health Ministry sources said that no decision has been taken on whether to procure the nasal vaccine for the national Covid-19 vaccination drive.

iNCOVACC (BBV154) was approved by the Central Drugs Standard Control Organization (CDSCO) earlier this month for use as a

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in